Every Mass Tort.
Litigation intelligence.
One feed.

MDL 3163 NAION rulings, optic neuropathy filings, and semaglutide vision-loss coverage

multidistrict filings, environmental rulemaking, and contamination coverage

federal MDL filings, state-court verdict activity, and carcinogenicity literature

bankruptcy-related filings, settlement developments, and epidemiology coverage

MDL 3094 gastroparesis rulings, GI injury pleadings, and semaglutide safety coverage

administrative claims, Eastern District filings, and legislative developments

FDA label changes, dental-injury pleadings, and addiction-treatment coverage

MDL 3084 scheduling orders, Uber safety disclosures, and legislative responses

Daubert rulings, appellate activity, and regulatory contamination updates

MDL 3171 scheduling orders, Lyft safety disclosures, and legislative responses

MDL 2846 bellwether scheduling, Bard and Davol settlement activity, and adverse-event tracking

MDL 3029 bellwether scheduling, Covidien motion practice, and adverse-event tracking

label updates, withdrawal news, and sickle-cell treatment studies

facility emissions litigation, EPA actions, and exposure science

oncology-label updates, checkpoint-inhibitor case filings, and clinical literature

survivor litigation, bankruptcy proceedings, and window legislation

design-defect pleadings, youth-protection policy, and behavioral-health research

product-liability filings, AI safety policy, and mental health research tied to conversational AI harms

remediation cases, contaminant rulemaking, and toxicology updates